Mace Health (02415) announced interim results. Profit attributable to shareholders of 248,000 yuan decreased by 97.9% year-on-year

According to the Zhitong Finance App, Mace Health (02415) announced interim results for the six months ended June 30, 2024. The group achieved revenue of RMB 111 million (same unit), a year-on-year decrease of 26.9%; profit attributable to owners of the parent company was 248,000 yuan, a year-on-year decrease of 97.9%; and earnings per share were 0.05 points.

According to the announcement, the decrease in revenue is mainly due to the increase in compliance requirements of current national standards faced by pharmaceutical and medical device companies and hospital doctors, and their compliance review period has been extended, thus extending the execution time of the project.